ESMO / ASCO recommendations for a global curriculum in medical oncology edition 2016 Journal Article


Authors: Dittrich, C.; Kosty, M.; Jezdic, S.; Pyle, D.; Berardi, R.; Bergh, J.; El-Saghir, N.; Lotz, J. P.; Österlund, P.; Pavlidis, N.; Purkalne, G.; Awada, A.; Banerjee, S.; Bhatia, S.; Bogaerts, J.; Buckner, J.; Cardoso, F.; Casali, P.; Chu, E.; Close, J. L.; Coiffier, B.; Connolly, R.; Coupland, S.; De Petris, L.; De Santis, M.; de Vries, E. G. E.; Dizon, D. S.; Duff, J.; Duska, L. R.; Eniu, A.; Ernstoff, M.; Felip, E.; Fey, M. F.; Gilbert, J.; Girard, N.; Glaudemans, A. W. J. M.; Gopalan, P. K.; Grothey, A.; Hahn, S. M.; Hanna, D.; Herold, C.; Herrstedt, J.; Homicsko, K.; Jones, D. V. Jr; Jost, L.; Keilholz, U.; Khan, S.; Kiss, A.; Köhne, C. H.; Kunstfeld, R.; Lenz, H. J.; Lichtman, S.; Licitra, L.; Lion, T.; Litière, S.; Liu, L.; Loehrer, P. J.; Markham, M. J.; Markman, B.; Mayerhoefer, M.; Meran, J. G.; Michielin, O.; Moser, E. C.; Mountzios, G.; Moynihan, T.; Nielsen, T.; Ohe, Y.; Öberg, K.; Palumbo, A.; Peccatori, F. A.; Pfeilstöcker, M.; Raut, C.; Remick, S. C.; Robson, M.; Rutkowski, P.; Salgado, R.; Schapira, L.; Schernhammer, E.; Schlumberger, M.; Schmoll, H. J.; Schnipper, L.; Sessa, C.; Shapiro, C. L.; Steele, J.; Sternberg, C. N.; Stiefel, F.; Strasser, F.; Stupp, R.; Sullivan, R.; Tabernero, J.; Travado, L.; Verheij, M.; Voest, E.; Vokes, E.; Von Roenn, J.; Weber, J. S.; Wildiers, H.; Yarden, Y.
Article Title: ESMO / ASCO recommendations for a global curriculum in medical oncology edition 2016
Abstract: The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) are publishing a new edition of the ESMO/ ASCO Global Curriculum (GC) thanks to contribution of 64 ESMOappointed and 32 ASCO-appointed authors. First published in 2004 and updated in 2010, the GC edition 2016 answers to the need for updated recommendations for the training of physicians in medical oncology by defining the standard to be fulfilled to qualify as medical oncologists. At times of internationalisation of healthcare and increased mobility of patients and physicians, the GC aims to provide state-of-the-art cancer care to all patients wherever they live. Recent progress in the field of cancer research has indeed resulted in diagnostic and therapeutic innovations such as targeted therapies as a standard therapeutic approach or personalised cancer medicine specialised training for medical oncology trainees. Thus, several new chapters on technical contents such as molecular pathology, translational research or molecular imaging and on conceptual attitudes towards human principles like genetic counselling or survivorship have been integrated in the GC. The GC edition 2016 consists of 12 sections with 17 subsections, 44 chapters and 35 subchapters, respectively. Besides renewal in its contents, the GC underwent a principal formal change taking into consideration modern didactic principles. It is presented in a template-based format that subcategorises the detailed outcome requirements into learning objectives, awareness, knowledge and skills. Consecutive steps will be those of harmonising and implementing teaching and assessment strategies.
Keywords: chemotherapy; renal-cell carcinoma; phase-iii trial; chronic lymphocytic-leukemia; clinical-practice guideline; international; cisplatin-based; metastatic prostate-cancer; gestational trophoblastic disease; consensus guidelines; cancer american society; myeloma working group
Journal Title: ESMO Open
Volume: 1
ISSN: 2059-7029
Publisher: European Society for Medical Oncology  
Date Published: 2016-09-30
Start Page: e000097
Language: English
ACCESSION: WOS:000408034800008
DOI: 10.1136/esmoopen-2016-000097
PROVIDER: wos
PMCID: PMC5070299
PUBMED: 27843641
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark E Robson
    676 Robson
  2. Stuart Lichtman
    228 Lichtman
Related MSK Work